Abbe Rubin

787 total citations
13 papers, 563 citations indexed

About

Abbe Rubin is a scholar working on Surgery, Oncology and Pharmacology. According to data from OpenAlex, Abbe Rubin has authored 13 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Abbe Rubin's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Abbe Rubin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Abbe Rubin collaborates with scholars based in United States and Canada. Abbe Rubin's co-authors include M. Juliana McElrath, Deborah Lee, Helen Horton, Ya-Lin Chiu, Marta E. Bull, Joan Korth‐Bradley, Donna Simcoe, Roberta Hanna, M. E. Lebsack and Edward A. Swabb and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of Virology.

In The Last Decade

Abbe Rubin

13 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abbe Rubin United States	10	160	149	122	87	75	13	563
Ramona Rajapakse United States	11	111 0.7×	181 1.2×	61 0.5×	54 0.6×	29 0.4×	30	568
Allyn B. Ley United States	12	62 0.4×	135 0.9×	61 0.5×	65 0.7×	64 0.9×	22	675
Helen Payne United Kingdom	9	125 0.8×	123 0.8×	31 0.3×	102 1.2×	157 2.1×	15	526
E Letessier France	15	168 1.1×	524 3.5×	43 0.4×	140 1.6×	19 0.3×	66	900
Kahan Bd United States	16	117 0.7×	191 1.3×	52 0.4×	130 1.5×	38 0.5×	85	670
Linda Scully Canada	17	91 0.6×	308 2.1×	26 0.2×	48 0.6×	161 2.1×	29	1.3k
Kelty R. Baker United States	10	78 0.5×	226 1.5×	15 0.1×	128 1.5×	39 0.5×	35	672
R Chapman United Kingdom	17	62 0.4×	549 3.7×	25 0.2×	31 0.4×	143 1.9×	30	1.1k
M.L. Sánchez Alegre United States	12	322 2.0×	162 1.1×	14 0.1×	105 1.2×	43 0.6×	28	654
Sheila Worlledge United Kingdom	19	263 1.6×	142 1.0×	59 0.5×	84 1.0×	120 1.6×	31	1.2k

Countries citing papers authored by Abbe Rubin

Since Specialization

Citations

This map shows the geographic impact of Abbe Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbe Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbe Rubin more than expected).

Fields of papers citing papers by Abbe Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abbe Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbe Rubin. The network helps show where Abbe Rubin may publish in the future.

Co-authorship network of co-authors of Abbe Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Abbe Rubin. A scholar is included among the top collaborators of Abbe Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abbe Rubin. Abbe Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Levitt, Martin, Mecide Gharibo, Roger Strair, et al.. (2009). Accelerated R-COP: A Pilot Study for the Treatment of Advanced Low Grade Lymphomas that Has a High Complete Response Rate. Journal of Chemotherapy. 21(4). 434–438. 2 indexed citations

Bull, Marta E., Deborah Lee, Ya-Lin Chiu, et al.. (2007). Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. Journal of Immunological Methods. 322(1-2). 57–69. 175 indexed citations

Horton, Helen, Colin Havenar‐Daughton, Deborah Lee, et al.. (2006). Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection. Journal of Virology. 80(19). 9779–9788. 14 indexed citations

Odaimi, Marcel, et al.. (2005). Updated results of a phase II trial of therapy with cyclophosphamide (CYP)/pentostatin/rituximab for indolent NHL and CLL. Journal of Clinical Oncology. 23(16_suppl). 6713–6713. 1 indexed citations

Gregory, Stephanie A., Julie Vose, Manuel Modiano, et al.. (2001). Mitoxantrone and Fludarabine in the Treatment of Patients with Non-Hodgkin's Lymphoma Failing Primary Therapy with a Doxorubicin-or Mitoxantrone-Containing Regimen. Leukemia & lymphoma. 40(3-4). 315–324. 10 indexed citations

Harvey, J. C., James Cantrell, Alan Cartmell, et al.. (2001). Mitoxantrone and Paclitaxel Combination Chemotherapy in Metastatic Breast Cancer. Cancer Investigation. 19(3). 225–233. 3 indexed citations

Korth‐Bradley, Joan, Abbe Rubin, Roberta Hanna, Donna Simcoe, & M. E. Lebsack. (2000). The Pharmacokinetics of Etanercept in Healthy Volunteers. Annals of Pharmacotherapy. 34(2). 161–164. 117 indexed citations

Jones, Sarah E., Robert Kirby, Robert Mennel, et al.. (1996). Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.. Journal of Clinical Oncology. 14(11). 2976–2983. 34 indexed citations

Lynch, David H., Abbe Rubin, R Eric Miller, & D E Williams. (1993). Protective effects of recombinant human interleukin-1 alpha in doxorubicin-treated normal and tumor-bearing mice.. PubMed. 53(7). 1565–70. 12 indexed citations

10.

Roufail, Walter M., Alphonso Belsito, Malcolm Robinson, Charles F. Barish, & Abbe Rubin. (1992). Ranitidine for erosive oesophagitis: a double‐blind, placebo‐controlled study. Alimentary Pharmacology & Therapeutics. 6(5). 597–607. 31 indexed citations

11.

Rubin, Abbe, et al.. (1989). A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.. PubMed. 84(6). 633–6. 42 indexed citations

12.

Lanza, Frank L., Richard L. Aspinall, Edward A. Swabb, et al.. (1988). Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology. 95(2). 289–294. 104 indexed citations

13.

Newman, Richard, et al.. (1987). Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy. The American Journal of Medicine. 83(1). 27–31. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact